
    
      The objective of the study is to determine the effect of prolonging total sleep time in
      migraineurs with insomnia on overall headache frequency, daytime alertness, fatigue, and
      functioning. The prolongation of total sleep time is accomplished by bedtime administration
      of 3 mg eszopiclone (Lunestaâ„¢), compared with placebo through a parallel-group design.
    
  